Navigation Links
New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses
Date:8/16/2011

SANTA ROSA, Calif., Aug. 16, 2011 /PRNewswire/ -- Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function. The study found that MCP activated B-cells in a dose-dependent manner, and induced a highly significant dose-dependent activation of T-cytotoxic cells and Natural Killer (NK) cells. The NK-cell's cancer killing activity was demonstrated against live leukemia cancer cells. The study is published in the journal BMC Complementary and Alternative Medicine. The research focuses on MCP's immunostimulatory properties in human blood samples, resulting in modulation of different arms of the immune system. Immune researchers at the Dharma Biomedical LLC (Miami, FL) are excited. "The dramatic ability of MCP to activate different components of both the innate (NK-cells) and adaptive (T-cytotoxic) arms of the immune system, demonstrates that MCP can be used in a very strategic manner to support immune function, which may prove useful for a variety of immune compromised health situations," says lead researcher Dr. Steve Melnick.MCP induced an increase in B-cells, T-cytotoxic cells, and NK-cells in a dose dependant manner, meaning the higher the dosage, the greater the effect. Researchers demonstrated that MCP induced a dramatic ten-fold increase in NK-cell activation, and furthermore a significant 53.6% increase in the NK-cells' functional ability to identify and destroy leukemia cancer cells.

Mechanism of Action (How MCP Works)

Melnick further explains, "The Modified Citrus Pectin used in this study consists of various polysaccharides that come in contact with different receptors or proteins on the membranes of immune cells. The immune cells become activated as a consequence of this very specific interaction." Melnick continues, "What I found impressive was the selectivity, and in those cases the magnitude
'/>"/>

SOURCE Better Health Publishing
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
2. Comparative Study Confirms Enox Biopharmas Antimicrobial Superiority to Commercially Available Silver Coated Catheters
3. Allergy Technologies LLC Provides Over $100,000 in a Research Grant to The Ohio State University for the Study of Bed Bugs
4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
5. BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study
6. Study Shows That Salt Lake City Based Company Has Program That Enhances Brain Activity
7. Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea
8. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
9. PCMA: Study Credits PBM Tools with Reducing Prescription Drug Spending Growth
10. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
11. Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
(Date:5/21/2013)...  BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC ... stem cell based therapies for various personal applications, announced ... and CEO, will be presenting at the Marcum MicroCap ... on Thursday, May 30, 2013 at the Grand Hyatt ... York City.  Mr. Weinreb,s presentation will take place at ...
(Date:5/21/2013)... SAN DIEGO , May 21, 2013 /PRNewswire/ ... from a secondary analysis of its double-blind, randomized, ... CERE-120 is a gene therapy product designed to ... This exploratory analysis identified a more robust response ... years prior to treatment relative to those diagnosed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
... 30 Although last year,s flu season was marked ... associated vaccine shortages, pharmacy experts at Cardinal Health expect ... 2010-2011 flu season. The upcoming 2010-2011 flu ... Advisory Committee on Immunization Practices (ACIP) has issued a ...
... YORK, Sept. 30 Reportlinker.com announces that a new market ... Drug Patent Inventor Report 2010 ... Report profiles the individuals, US states, and countries leading pharmaceutical ... to 2009, this report provides complete lists of: ...
Cached Medicine Technology:Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 3Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 4Reportlinker Adds Drug Patent Inventor Report 2010 2
(Date:5/21/2013)... significantly more likely than their normal-weight counterparts to ... disrupts continuity of care and leads to more ... , The practice of "doctor shopping" among overweight ... with the health care system, whether that be ... advice by providers, or improperly sized medical equipment ...
(Date:5/21/2013)... Children using the abutment-free implantable bone ... results comparable to the traditionally used, competitive abutment ... to a new study. , “The results are ... performs just as well as technology with a ... says Jim Kasic, president and CEO of Sophono. ...
(Date:5/21/2013)... News) -- Urban elementary school children with poorly ... and suffer academically, new research indicates. "In ... nine, we found that compromised lung function corresponded ... performance," said study author Daphne Koinis-Mitchell, an ... Brown University,s Alpert Medical School in Providence, R.I. ...
(Date:5/21/2013)... nanoparticles are usually toxic to cells, but cancer ... Clinic researchers found out why, and determined how ... cells. The discovery is detailed in the current ... Chemistry ., "This study identifies a novel mechanism ... cell death or apoptosis which should occur when ...
(Date:5/21/2013)... Representatives with Hammerhead Bicycles announced today that ... the company has achieved its overall goal of becoming a ... to move Hammerhead Bicycles from a house brand to a ... , Robertson explained that the bike shop will go forward ... on all things 29er and 650b. , “The ...
Breaking Medicine News(10 mins):Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Sleepless Nights May Hurt School Performance of Kids With Asthma 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Hammerhead Bicycles Now a Standalone Brand 2
... Medical Record/Practice Management Software Company Aimed at Giving ... HILLS, Mich., May 27 gloStream, a healthcare ... Office embedded electronic medical record ("EMR") and practice ... closed on a $7.5 million series B financing ...
... When Chicago Blackhawk,s leading scorer Martin Havlat returned ... Conference Final after sustaining a concussion only two days ... to a new study by St. Michael,s Hospital neurosurgeon ... of minor league hockey players who did not know ...
... to healthier livesST. LOUIS, May 27 Nurse Response ... new consumer health tool that will complement the quality ... Response will offer the Healthwise Knowledgebase, an online consumer ... to access over 7,000 health topics online. , ...
... York, NY / Los Angeles, CA: Stand Up ... aimed at getting new cancer treatments to patients in ... the first round of three-year grants that total ... Teams. The majority of these funds were raised in ...
... The Institute for Palliative Medicine plays unique roleSAN DIEGO, ... Irwin, M.D., Ph.D., Director of the Palliative Care Psychiatry ... been elected as a Member of The American College ... one of only 750 practicing psychiatrists nationwide who have ...
... for stricter regulatory approval requirements and continuity of product supply. ... ... A recent report released by Wolters Kluwer Health predicts that by ... will be filled with generic drugs. This march to generics ...
Cached Medicine News:Health News:gloStream Announces $7.5 Million Series B Financing Round Co-Led by Beringea and gloStream's Executive Management Team 2Health News:gloStream Announces $7.5 Million Series B Financing Round Co-Led by Beringea and gloStream's Executive Management Team 3Health News:gloStream Announces $7.5 Million Series B Financing Round Co-Led by Beringea and gloStream's Executive Management Team 4Health News:Minor league hockey players unable to identify concussion symptoms, study says 2Health News:Minor league hockey players unable to identify concussion symptoms, study says 3Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 2Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 3Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 4Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 5Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 6Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 7Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 8Health News:San Diego Psychiatrist Scott Irwin Honored With National Recognition 2Health News:San Diego Psychiatrist Scott Irwin Honored With National Recognition 3Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 2Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 3Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 4Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 5
The most compact revolutionary innovation in hematology. 3 Part DIFF + CRP measurement on whole blood....
... Evolis™ is a self contained microplate ... based EIA assays. The system is dedicated ... encountered in todays busy laboratory. The system ... of EIA assays that satisfy their microplate ...
... Retrieval System is made up of three ... Microcatheter and the Merci Balloon Guide Catheter. ... the location of the clot has been ... Catheter is inserted through a small incision ...
... 3080/3085 SP Bariatric Foot Extension provides extraordinary ... surgical capabilities for Amsco 3080 and 3085 ... Extension is rated for patients up to ... and easy attachment and full positioning capability. ...
Medicine Products: